redefining low risk high hyperdiploidy in pediatric all
Published 3 years ago • 448 plays • Length 5:23Download video MP4
Download video MP3
Similar videos
-
3:35
analysis from most: disease progression and leukemic transformation in lower-risk myelofibrosis
-
3:16
the management of high-risk all
-
2:48
epigenetic profiling and machine learning for risk stratification in pediatric all
-
3:00
processes leading to the development of hyperdiploidy in multiple myeloma
-
2:41
safety and efficacy of actaly-cel™ in r/r pediatric b-all
-
1:32
next-generation sequencing for low-risk mds
-
1:33
venetoclax with mini-hyper-cvd for all
-
1:04
defining high-risk cll: known and emerging mutations
-
1:02
update on treatments for high- and low-risk mds
-
1:21
trends in allosct for good-risk aml: a longitudinal study
-
2:24
comparing allosct outcomes in secondary and de-novo acute lymphoblastic leukemia
-
2:12
allre08 pethema: pediatric regimen for adolescents with ph-negative all
-
1:01
the current landscape of antibody-based therapies in r/r dlbcl
-
1:27
pre-leukemic state and cll show similar genomic landscapes: what does this tell us?
-
1:49
the importance of better understanding the genomic landscape of follicular lymphoma
-
1:12
exciting advances in dlbcl: molecular characterization of subtypes & novel immunotherapeutic agents
-
2:41
an overview of the latest advances in hematology
-
1:03
the growing importance of single-cell rna sequencing in hematology
-
2:51
ruxolitinib in combination with abemaciclib for patients with primary or post-pv/et myelofibrosis